Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > MediPharm Labs Posts Q3 Revenues of $5.4 Million, Continues

<< Previous

Bullboard Posts

Next >>

Comment by Righttothetopon Nov 15, 2021 9:12am

122 Views

Post# 34126459

RE:MediPharm Labs Posts Q3 Revenues of $5.4 Million, Continues

Go away Lutz....anyone following this company know you hate it and always have for reasons unknown.....this Q report shows positive indications that they have turned a corner....it ain't all sunshine and lollypops but it's not all doom and gloom either (for a welcome change).

AwareInvestor wrote:
MediPharm Labs this morning reported its third quarter financial results, posting revenues of $5.4 million for the quarter. The firm also posted a net loss of $7.4 million for the period, along with continuing the trend of negative gross margins.

https://thedeepdive.ca/medipharm-labs-posts-q3-revenues-of-5-4-million-continues-to-post-negative-gross-margins/